Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Fintel reports that on January 7, 2025, Evercore ISI Group upgraded their outlook for Labcorp Holdings (NYSE:LH) from In-Line ...

LabCorp and University Health System settle on $388,667 for alleged False Claims Act violations related to Medicare billing.

In the preceding three months, 8 analysts have released ratings for Labcorp Holdings LH +2.25% Get Free Report , presenting a wide array of perspectives from bullish to bearish. The following table ...

The Federal Circuit rejected Laboratory Corporation of America Holdings’ challenge of a competitor’s fetal DNA test patent ...

The U.S. Attorney's Office said the two corporations delayed certain laboratory tests by Caris Life Sciences between March ...

The Federal Circuit on Monday, January 6, rejected Labcorp's argument that the Patent Trial and Appeal Board erred in its ...

With a market cap of $19.2 billion, Labcorp Holdings Inc. (LH) is a leading global life sciences company specializing in ...

University Health System and Labcorp pay $388,667 to resolve False Claims Act allegations of improper billing to Medicare for lab tests.

The bank upgraded Labcorp's stock on expectations of solid lab volume growth, accretive revenues from Labcorp's Invitae business, and margin expansion in 2025.

Labcorp Holdings' (NYSE:LH) stock up by 5.0% over the past three months. However, we decided to study the company's mixed-bag of fundamentals to assess what this could mean for future share prices, as ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...